FTC sues Hims & Hers for allegedly sharing patients’ medical data with advertisers Meta and Snap
The Federal Trade Commission is suing healthcare giant Hims & Hers for allegedly sharing its customers’ medical and…
Hims & Hers Adds Lilly GLP-1 Treatments To Lineup – CEO Compares It To Netflix’s Early Days
Hims & Hers announced that Lilly’s Zepbound, Mounjaro, and Foundayo are now available to providers on the platform,…
Hims & Hers will sell real Ozempic in deal with Novo Nordisk
Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will…
The era of $199 copycat weight loss drugs is ending — and it could cost patients
After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
The telehealth company Hims & Hers (NYSE: HIMS), which provides consultations and prescriptions, saw its stock crater by…